parthenolide has been researched along with ginsenosides in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Pestka, JJ; Smolinski, AT | 1 |
| Jin, X; Lv, H; Zhang, Z; Zhou, J | 1 |
| Cai, N; Jin, X; Yang, Q; Zhang, Z | 1 |
3 other study(ies) available for parthenolide and ginsenosides
| Article | Year |
|---|---|
Modulation of lipopolysaccharide-induced proinflammatory cytokine production in vitro and in vivo by the herbal constituents apigenin (chamomile), ginsenoside Rb(1) (ginseng) and parthenolide (feverfew).
Topics: Animals; Apigenin; Cell Line; Chamomile; Cytokines; Enzyme-Linked Immunosorbent Assay; Flavonoids; Ginsenosides; Interleukin-6; Lipopolysaccharides; Macrophages; Mice; Panax; Sesquiterpenes; Tanacetum parthenium; Tumor Necrosis Factor-alpha | 2003 |
The combined administration of parthenolide and ginsenoside CK in long circulation liposomes with targeted tLyp-1 ligand induce mitochondria-mediated lung cancer apoptosis.
Topics: A549 Cells; Animals; Apoptosis; Delayed-Action Preparations; Ginsenosides; Humans; Liposomes; Lung Neoplasms; Mice; Mice, Nude; Mitochondria; Reactive Oxygen Species; Sesquiterpenes; Xenograft Model Antitumor Assays | 2018 |
A cocktail of betulinic acid, parthenolide, honokiol and ginsenoside Rh2 in liposome systems for lung cancer treatment.
Topics: A549 Cells; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Betulinic Acid; Biphenyl Compounds; Cell Proliferation; Cisplatin; Ginsenosides; Humans; Lignans; Liposomes; Lung Neoplasms; Mice; Neoplasm Invasiveness; Pentacyclic Triterpenes; Sesquiterpenes; Triterpenes; Xenograft Model Antitumor Assays | 2020 |